From the ability to successfully manipulate the mouse genome has come impor
tant transgenic and gene-targeted knockout models that impact many areas of
biomedical research. Genetically engineered mouse models geared toward the
study of cardiovascular regulation have recently been described and provid
e powerful tools to study normal and compromised cardiac physiology. The ge
netic manipulation of the adrenergic receptor (AR) signaling system in the
heart, including its regulation by desensitizing kinases, has shed light on
the role of this signaling pathway in the regulation of cardiac contractil
ity. One major finding, supported by several mouse models, is that in vivo
contractility can be enhanced via alteration of myocardial AR signaling. Th
us genetic manipulation of this critical receptor system in the heart repre
sents a novel therapeutic approach for improving function of the failing he
art.